I'm not a big fan of uplisting right now either. Here's the PR: http://cellceutix.com/cellceutix-appoints-dr-barry-schechter-to-board-of-directors-as-company-focuses-on-meeting-requirements-for-stock-exchange-uplisting/#sthash.AW5OUBVs.dpbs